Universitätsklinik für Innere Medizin IV

M. Rudnicki, J. Kerschbaum, J. Hausdorfer, G. Mayer, P. König

RISK FACTORS FOR PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS: THE ROLE OF ORAL ACTIVE VITAMIN D

Peritoneal Dialysis International 2010 30: in press

P. Eller, K. Eller, AM. Wolf, SJ. Reinstadler, A. Tagwerker, JR. Patsch, G. Mayer, AR. Rosenkranz

ATORVASTATIN ATTENUATES MURINE ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS

Kidney International 2010 77: 428-435

K. Eller, T. Weber, M. Pruenster, AM. Wolf, G. Mayer, AR. Rosenkranz, A. Rot

CCR7 DEFICIENCY EXACERBATES INJURY IN ACUTE NEPHRITIS DUE TO ABERRANT LOCALIZATION OF REGULATORY T CELLS

Journal of the American Society of Nephrology 2010 21: 42-52

A. Schroll, K. Eller, JM. Huber, IM. Theurl, AM. Wolf, G. Weiss, AR. Rosenkranz

TIM3 IS UPREGULATED AND PROTECTIVE IN NEPHROTOXIC SERUM NEPHRITIS

The American Journal of Pathology 2010 176: 1716-24

P. Eller, K. Hochegger

HONEY INTOXICATION AND THE BEZOLD-JARISCH REFLEX

International Journal of Cardiology 2009 Jan 26: ahead of print

C. Koppelstaetter, G. Kern, G. Mayer

BIOMARKERS OF AGING WITH PROGNOSTIC AND PREDICTIVE VALUE IN NON-ONCOLOGICAL DISEASES

Current Medicinal Chemistry 2009 16: 3469-3475

G. Schernthaner, H. Baumgartner, M. Lechleitner, G. Mayer, J. Slany

ANTIHYPERTENSIVE THERAPY OF DIABETES MELLITUS

Wiener Klinische Wochenschrift: 2009 121: S22-S24

M. Auinger, R. Edlinger, F. Prischl, A. Kautzky-Willer, R. Prager, G. Mayer, M. Roden

DIABETISCHE NEPHROPATHIE - UPDATE 2009 LEITLINIEN DER ÖSTERREICHISCHEN DIABETES GESELLSCHAFT UND DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEPHROLOGIE

Wiener Klinische Wochenschrift 2009 121: S37-S42

K. Lhotta, A. Gehringer, P. Jennings, F. Kronenberg, C. Brezinka, I. Andersone, V. Strazdins

FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY: REPORT ON A NEW MUTATION AND A PREGNANCY

Clinical Nephrology 2009 71: 80-83

M. Burg, MD. Säemann, C. Wieser, S. Kramer, W. Fischer, K. Lhotta

ENTERIC-COATED MYCOPHENOLATE SODIUM REDUCES GASTROINTESTINAL SYMPTOMS IN RENAL TRANSPLANT PATIENTS

Transplantation Proceedings 2009 41: 4159-4164

K. Lhotta, AR. Janecke, J. Scheiring, B. Petzlberger, T. Giner, V. Fally, R. Würzner, LB. Zimmerhackl, G. Mayer, V. Fremeaux-Bacchi

A LARGE FAMILY WITH A GAIN-OF-FUNCTION MUTATION OF COMPLEMENT C3 PREDISPOSING TO ATYPICAL HEMOLYTIC UREMIC SYNDROME, MICROHEMATURIA, HYPERTENSION AND CHRONIC RENAL FAILURE

Clinical Journal of the American Society of Nephrology 2009 4: 1356-1362

G. Kopriva-Altfahrt, P. König, M. Mündle, F. Prischl, JM. Roob, M. Wiesholzer, A. Vychytil; Austrian Study Group for Prevention of Peritoneal Catheter-Associated Infections, K. Arneitz, A. Karner, R. Artes, E. Wolf, M. Auinger, A. Pawlak, J. Fraberger, S. Hofbauer, G. Galvan, H. Salmhofer, B. Pichler, M. Wazel, M. Gruber, A. Thonhofer, A. Hager, S. Malajner, S. Heiss, T. Braunsteiner, M. Zweiffler, P. König, M. Rudnicki, R. Kogler, D. Kohlhauser, T. Wiesinger, G. Kopriva-Altfahrt, E. Moser, P. Kotanko, H. Loibner, H. Nitz, HJ. Miska, R. Wenzel, M. Wölfer, M. Mündle, H. Breuss, B. Hölzl, F. Prischi, B. Schmekal, EM. Riener, JM. Roob, W. Wonisch, R. Vikydal, A. Vychytil, B. Frank, C. Wieser, M. Wiesholzer, K. Pokorny

EXIT-SITE CARE IN AUSTRIAN PERITONEAL DIALYSIS CENTERS - A NATIONWIDE SURVEY

Peritoneal Dialysis International 2009 29: 330-339

K. Hochegger, E. Wurz, D. Nachbaur, AR. Rosenkranz, J. Clausen

RAPAMYCIN-INDUCED PROTEINURIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Bone Marrow Transplantation 2009 44: 63-65

AM. Wolf, K. Eller, R. Zeiser, C. Dürr, UV. Gerlach, M. Sixt, L. Markut, G. Gastl, AR. Rosenkranz, D. Wolf

THE SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST FTY720 POTENTLY INHIBITS REGULATORY T CELL PROLIFERATION IN VITRO AND IN VIVO

Journal of Immunology 2009 183: 3751-3760

G. Weiss, I. Theurl, S. Eder, C. Koppelstaetter, K. Kurz, T. Sonnweber, U. Kobold, G. Mayer

SERUM HEPCIDIN CONCENTRATION IN CHRONIC HAEMODIALYSIS PATIENTS: ASSOCIATIONS AND EFFECTS OF DIALYSIS, IRON AND ERYTHROPOIETIN THERAPY

European Journal of Clinical Investigation 2009 39: 883-890

B. Glodny, J. Petersen, KJ. Hofmann, C. Schenk, R. Herwig, T. Trieb, C. Koppelstaetter, I. Steingruber, P. Rehder

KIDNEY FUSION ANOMALIES REVISITED: CLINICAL AND RADIOLOGICAL ANALYSIS OF 209 CASES OF CROSSED FUSED ECTOPIA AND HORSESHOE KIDNEY

BJU International 2009 103: 224-235

J. Hofer, S. Hofer, M. Zlamy, V. Jeller, C. Koppelstaetter, A. Brandstätter, H. Kern, J. Köhle, LB. Zimmerhackl, M. Prelog

ELEVATED PROPORTIONS OF RECENT THYMIC EMIGRANTS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES

Rejuvenation Research 2009 12: 311-320

JM. Huber, A. Tagwerker, D. Heininger, G. Mayer, AR. Rosenkranz, K. Eller

THE PROTEASOME INHIBITOR BORTEZOMIB AGGRAVATES RENAL ISCHEMIA-REPERFUSION INJURY

American Journal of Physiology: Renal Physiology 2009 297: F451-460

H. Schramek, R. Sarközi, C. Lauterberg, A. Kronbichler, M. Pirklbauer, R. Albrecht, SJ. Noppert, P. Perco, M. Rudnicki, FM. Strutz, G. Mayer

NEUROPILIN-1 AND NEUROPILIN-2 ARE DIFFERENTIALLY EXPRESSED IN HUMAN PROTEINURIC NEPHROPATHIES AND CYTOKINE-STIMULATED PROXIMAL TUBULAR CELLS

Laboratory Investigation 2009 89: 1304-1316

BC. Fellstrom, AG. Jardine, RE. Schmieder, H. Holdaas, K. Bannister, J. Beutler, DW. Chae, A. Chevaile, SM. Cobbe, C. Gronhagen-Riska, JJ. De Lima, R. Lins, G. Mayer, AW. McMahon, HH. Parving, G. Remuzzi, O. Samuelsson, S. Sonkodi, G. Suleymanlar, D. Tsakiris, V. Tesar, V. Todorov, A. Wiecek, RP. Wuthrich, M. Gottlow, E. Johnsson, F. Zannad

ROSUVASTATIN AND CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING HEMODIALYSIS

The New England Journal of Medicine 2009 360: 1395-1407

G. Heinze, R. Oberbauer, A. Kainz, C. Mitterbauer, C. Koppelstaetter, WH. Hörl, G. Mayer

CALCINEURIN INHIBITOR BASED IMMUNOSUPPRESSIVE THERAPY, DONOR AGE AND LONG TERM OUTCOME AFTER KIDNEY TRANSPLANTATION

Transplantation 2009 87: 1821-1829

A. Wehinger, I. Tancevski, R. Seiler, SM. Frotschnig, S. Frantz, J. Huber, P. Eller, W. Schgoer, B. Foeger, .JR. Patsch, A. Ritsch

INFLUENCE OF ASPIRIN ON SR-BI EXPRESSION IN HUMAN CAROTID PLAQUES

Atherosclerosis 2009 206: 234-238

U. Heidenreich, G. Mayer, M. Herold, W. Klotz, K. Stempfl Al-Jazrawi, K. Lhotta

SENSITIVITY AND SPECIFICITY OF AUTOANTIBODY TESTS IN THE DIFFERENTIAL DIAGNOSIS OF LUPUS NEPHRITIS

Lupus 2009 18: 1276-1280

CP. Schwarz, C. Koppelstaetter, E. Amann, G. Mayer

IMPACT OF ANEMIA ON AORTIC PULSE WAVE VELOCITY IN HEMODIALYSIS PATIENTS

Kidney and Blood Pressure Research 2009 32: 210-216

M. Rudnicki, P. Perco, J. Enrich, S. Eder, D. Heininger, A. Bernthaler, M. Wiesinger, R. Sarközi, SJ. Noppert, H. Schramek, B. Mayer, R. Oberbauer, G. Mayer

HYPOXIA RESPONSE AND VEGF-A EXPRESSION IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS IN STABLE AND PROGRESSIVE RENAL DISEASE

Laboratory Investigation 2009 89: 337-346

M. Rudnicki, G. Mayer

SIGNIFICANCE OF GENETIC POLYMORPHISMS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN CARDIOVASCULAR AND RENAL DISEASE

Pharmacogenomics 2009 10: 463-476

I. Tancevski, A. Wehinger, E. Demetz, P. Eller, K. Duwensee, J. Huber, K. Hochegger, W. Schgoer, C. Fievet, F. Stellaard, M. Rudling, JR.Patsch, A. Ritsch

REDUCED PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN HYPERTHYROID MICE COINCIDES WITH DECREASED HEPATIC ADENOSINE 5'-TRIPHOSPHATE-BINDING CASSETTE TRANSPORTER 1 EXPRESSION

Endocrinology 2008 149: 3708-3712

V. Frémeaux-Bacchi, EC. Miller, MK. Liszewski, L. Strain, J. Blouin, AL. Brown, N. Moghal, BS. Kaplan, RA. Weiss, K. Lhotta, G. Kapur, T. Mattoo, H. Nivet, W. Wong, S. Gie, B. Hurault de Ligny, M. Fischbach, R. Gupta, R. Hauhart, V. Meunier, C. Loirat, MA. Dragon-Durey, WH. Fridman, BJ. Janssen, TH. Goodship, JP. Atkinson

MUTATIONS IN COMPLEMENT C3 PREDISPOSE TO DEVELOPMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME

Blood 2008 112: 4948-4952

R. Sarközi, P. Perco, K. Hochegger, J. Enrich, M. Wiesinger, M. Pirklbauer, S. Eder, M. Rudnicki, AR. Rosenkranz, B. Mayer, G. Mayer, H. Schramek

BORTEZOMIB-INDUCED SURVIVAL SIGNALS AND GENES IN HUMAN PROXIMAL TUBULAR CELLS

Journal of Pharmacology and Experimental Therapeutics 2008 327: 645-656

P. Eller, K. Hochegger, GM. Feuchtner, E. Zitt, I. Tancevski, A. Ritsch, F. Kronenberg, AR. Rosenkranz, JR. Patsch, G. Mayer

IMPACT OF ENPP1 GENOTYPE ON ARTERIAL CALCIFICATION IN PATIENTS WITH END-STAGE RENAL FAILURE

Nephrology Dialysis Transplantation 2008 23: 321-327

K. Hochegger, GL. Jansky, A. Soleiman, AM. Wolf, A. Tagwerker, C. Seger, A. Griesmacher, G. Mayer, AR. Rosenkranz

DIFFERENTIAL EFFECTS OF RAPAMYCIN IN ANTI-GBM GLOMERULONEPHRITIS

Journal of the American Society of Nephrology 2008 19: 1520-1529

E. Zitt, U. Neyer, E. Meusburger, M. Tiefenthaler, P. Kotanko, G. Mayer, AR. Rosenkranz

EFFECT OF DIALYSATE TEMPERATURE AND DIABETES ON AUTONOMIC CARDIOVASCULAR REGULATION DURING HEMODIALYSIS

Kidney and Blood Pressure Research 2008 31: 217-225

C. Koppelstätter, G. Schratzberger, P. Perco, J. Hofer, W. Mark, R. Ollinger, R. Oberbauer, C. Schwarz, C. Mitterbauer, A. Kainz, H. Karkoszka, A. Wiecek, B. Mayer, G. Mayer

MARKERS OF CELLULAR SENESCENCE IN ZERO HOUR BIOPSIES PREDICT OUTCOME IN RENAL TRANSPLANTATION. CELLULAR SENESCENCE AND LONG TERM RENAL ALLOGRAFT FUNCTION.

Aging Cell 2008 7: 491-497

G. Gollmann, H. Neuwirt, CH. Tripp, H. Mueller, G. Konwalinka, C. Heufler, N. Romani, M. Tiefenthaler

SPHINGOSINE-1-PHOSPHATE RECEPTOR TYPE 1 AGONISM IMPAIRS BLOOD DENDRITIC CELL CHEMOTAXIS AND SKIN DENDRITIC CELL MIGRATION TO LYMPH NODES UNDER INFLAMMATORY CONDITIONS

International Immunology 2008 20: 911-923

Wehinger A, Tancevski I, Schgoer W, Eller P, Hochegger K, Morak M, Hermetter A, Ritsch A, Patsch JR, Foeger B.

PHOSPHOLIPID TRANSFER PROTEIN AUGMENTS APOPTOSIS IN THP-1-DERIVED MACROPHAGES INDUCED BY LIPOLYZED HYPERTRIGLYCERIDEMIC PLASMA

Arterioscler Thromb Vasc Biol. 2007 27: 908-915

C. Falkeis, W. Mark, C. Sergi, D. Heininger, F. Neumair, J. Scheiring, K. Lhotta

KIDNEY TRANSPLANTATION IN PATIENTS SUFFERING FROM HEREDITARY COMPLETE COMPLEMENT C4 DEFICIENCY

Transplant International 2007 20: 1044-1049

P. Eller, S. Kaser, K. Lhotta, EL. Edghill, S. Ellard, C. Ebenbichler, JR. Patsch

RENAL CYSTS AND DIABETES DUE TO A HETEROZYGOUS HNF-1BETA GENE DELETION

Nephrology Dialysis Transplantation 2007 22: 1271-1272

P. Jennings, S. Aydin, P. Kotanko, J. Lechner, K. Lhotta, S. Williams, RV. Thakker, W. Pfaller

MEMBRANE TARGETING AND SECRETION OF MUTANT UROMODULIN IN FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY

Journal of the American Society of Nephrology 2007 18: 264-273

D. Fliser, B. Kollerits, U. Neyer, DP. Ankerst, K. Lhotta, A. Lingenhel, E. Ritz, F. Kronenberg

FIBROBLAST GROWTH FACTOR 23 (FGF23) PREDICTS PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY DISEASE (MMKD) STUDY

Journal of the American Society of Nephrology 2007 18: 2600-2608

M. Andratsch, E. Feifel, L. Taylor, M. O’Hayre, H. Schramek, NP. Curthoys, G. Gstraunthaler

FTGF-{BETA} SIGNALING AND ITS EFFECT ON GLUTAMINASE EXPRESSION IN LLC-PK1-FBPase+ CELLS

American Journal of Physiology: Renal Physiology 2007 293: F846-853

JP. Schwaiger, G. Kopriva-Altfahrt, W. Söllner, P. Köni

PERSONAL ABILITIES IN PATIENTS UNDERGOING PERITONEAL DIALYSIS AND HEMODIALYSIS. A PILOT STUDY USING THE EXISTENCE SCALE

Wiener Klinische Wochenschrift 2007 119: 350-354

ME. Frischmann, F. Kronenberg, E. Trenkwalder, JR. Schäfer, H. Schweer, B. Dieplinger, P. König, K. Ikewaki, H. Dieplinger

IN VIVO TURNOVER STUDY DEMONSTRATES DIMINISHED CLEARANCE OF LIPOPROTEIN(A) IN HEMODIALYSIS PATIENTS

Kidney International 2007 71: 1036-1043

KS. Spanaus, F. Kronenberg, E. Ritz, R. Schlapbach, D. Fliser, M. Hersberger, B. Kollerits, P. König, A. von Eckardstein

B-TYPE NATRIURETIC PEPTIDE CONCENTRATIONS PREDICT THE PROGRESSION OF NONDIABETIC CHRONIC KIDNEY DISEASE: THE MILD-TO-MODERATE KIDNEY DISEASE STUDY

Clinical Chemistry 2007 53: 1264-1272

Eller P, Hochegger K, Wehinger A, Tancevski I, Schgoer W, Ritsch A, Patsch JR

HEPATIC ENPP1 EXPRESSION IS INDUCED IN DIABETIC RABBITS

Mamm Genome. 2006 17: 886-891

M. Oehlbauer, B. Zelger, AR. Rosenkranz, P. Pulzl, G. Wechselberger

CALCIPHYLAXIS IN A PATIENT WITH CHRONIC DIABETIC RENAL FAILURE BUT NORMAL PARATHORMONE

Plastic and Reconstructive Surgery 2006 117: 1367-1368

B. Nashan, B. Suwelack, K. Ivens, W. Arns, K. Lhotta, B. Bourbigot, K. Budde, W. Fischer, F. Pietruck, ERL2405-DE02 Study Group

CONVERSION TO ENTERIC-COATED MYCOPHENOLATE SODIUM FROM VARIOUS DOSES OF MYCOPHENOLATE MOFETIL: RESULTS OF A PROSPECTIVE INTERNATIONAL MULTICENTER TRIAL IN MAINTENANCE RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE

Transplantation Proceedings 2006 38: 2856-2859

C. Schubert, B. Noisternig, D. Fuchs, P. König, E. Chamson, S. Mittnik, G. Schüßler, W. Geser

MULTI-FACETED EFFECTS OF POSITIVE INCIDENTS ON STRESS SYSTEM FUNCTIONING IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Stress and Health 2006 22: 215-227

A. Lingenhel, K. Lhotta, U. Neyer, IM. Heid, B. Rantner, MF. Kronenberg, P. König, A. von Eckardstein, M. Schober, H. Dieplinger, F. Kronenberg

ROLE OF THE KIDNEY IN THE METABOLISM OF APOLIPOPROTEIN A-IV: INFLUENCE OF THE TYPE OF PROTEINURIA

Journal of Lipid Research 2006 47: 2071-2079

K. Lhotta

THE ROLE OF GENDER IN ESTIMATING GLOMERULAR FILTRATION RATE

Nephrology Dialysis Transplantation 2006 21: 819

JP. Schwaiger, C. Lamina, U. Neyer, P. König, H. Kathrein, W. Sturm, K. Lhotta, E. Gröchenig, H. Dieplinger, F. Kronenberg

CAROTID PLAQUES AND THEIR PREDICTIVE VALUE FOR CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS CONSIDERING RENAL TRANSPLANTATION: A DECADE FOLLOW-UP

American Journal of Kidney Diseases 2006 47: 888-897

B. Hugl, K. Lhotta, C. Ensinger, M. Cont, R. Kafka, R. Margreiter, A. Rosenkranz, H. Bonatti

COLONIC PERFORATION ASSOCIATED WITH LEUKOCYTOCLASTIC VASCULITIS CAUSED BY SIROLIMUS TOXICITY FOLLOWING RENAL TRANSPLANTATION

Transplantation International 2006 19: 430-431

K. Hochegger, J. Gruber, K. Lhotta

ACUTE INFLAMMATORY SYNDROME INDUCED BY MYCOPHENOLATE MOFETIL IN A PATIENT FOLLOWING KIDNEY TRANSPLANTATION

American Journal of Transplantation 2006 6: 852-854

J. Calado, J. Löffler, O. Sakallioglu, F. Gok, K. Lhotta, J. Barata, J. Rueff

FAMILIAL RENAL GLUCOSURIA: SLC5A2 MUTATION ANALYSIS AND EVIDENCE OF SALT-WASTING

Kidney International 2006 69: 852-855

E. Boes, D. Fliser, E. Ritz, P. König, K. Lhotta, JF. Mann, GA. Müller, U. Neyer, W. Riegel, P. Riegler, F. Kronenberg

APOLIPOPROTEIN A-IV PREDICTS PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY DISEASE STUDY

Journal of the American Society of Nephrology 2006 17: 528-536

H. Neuwirt, H. Müller, IT. Cavarretta, M. Tiefenthaler, G. Bartsch, G. Konwalinka, Z. Culig

AKACID-MEDICAL-FORMULATION, A NOVEL BIOCIDAL OLIGOGUANIDINE WITH ANTITUMOR ACTIVITY REDUCES S-PHASE IN PROSTATE CANCER CELL LINES THROUGH THE ERK 1/2 MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY

International Journal of Oncology 2006 29: 503-512

N. Bacher, M. Tiefenthaler, S. Sturm, H. Stuppner, MJ. Ausserlechner, R. Kofler, G. Konwalinka

OXINDOLE ALKALOIDS FROM UNCARIA TOMENTOSA INDUCE APOPTOSIS IN PROLIFERATING, G0/G1-ARRESTED AND BCL-2-EXPRESSING ACUTE LYMPHOBLASTIC LEUKAEMIA CELLS

British Journal of Haematology 2006 132: 615-622

G. Untergasser, R. Köck, D. Wolf, H. Rumpold, H. Ott, P. Debbage, C. Koppelstaetter, E. Gunsilius

CD34+/CD133- CIRCULATING ENDOTHELIAL PRECURSOR CELLS (CEP): CHARACTERIZATION, SENESCENCE AND IN VIVO APPLICATION

Experimental Gerontology 2006 41: 600-608

K. Ikewaki, JR. Schäfer, ME. Frischmann, K. Okubo, T. Hosoya, S. Mochizuki, B. Dieplinger, E. Trenkwalder, H. Schweer, F. Kronenberg, P. Koenig, H. Dieplinger

DELAYED IN VIVO CATABOLISM OF INTERMEDIATE-DENSITY LIPOPROTEIN AND LOW-DENSITY LIPOPROTEIN IN HEMODIALYSIS PATIENTS AS POTENTIAL CAUSE OF PREMATURE ATHEROSCLEROSIS

Arteriosclerosis Thrombosis and Vascular Biology 2005 25: 2615-2622

H. Müller, S. Hofer, N. Kaneider, H. Neuwirt, B. Mosheimer, G. Mayer, G. Konwalinka, C. Heufler, M. Tiefenthaler

THE IMMUNOMODULATOR FTY720 INTERFERES WITH EFFECTOR FUNCTIONS OF HUMAN MONOCYTE-DERIVED DENDRITIC CELLS

European Journal of Immunology 2005 35: 533-545

M. Joannidis, S. Truebsbach, K. Bijuklic, P. Schratzberger, S. Dunzedorfer, S. Wintersteiger, K. Lhotta, G. Mayer, CJ. Wiedermann

NEUTROPHIL TRANSMIGRATION IN RENAL PROXIMAL TUBULAR LLC-PK1 CELLS

Cellular Physiology and Biochemistry 2004 14: 101-112

A. Kainz, C. Mitterbauer, P. Hauser, C. Schwarz, HM. Regele, G. Berlakovich, G. Mayer, P. Perco, B. Mayer, TW. Meyer, R. Oberbauer

ALTERATIONS IN GENE EXPRESSION IN CADAVERIC VS. LIVE DONOR KIDNEYS SUGGEST IMPAIRED TUBULAR COUNTERBALANCE OF OXIDATIVE STRESS AT IMPLANTATION

American Journal of Transplantation 2004 4: 1595-1604

H. Kotzmann, M. Riedl, P. Pietschmann, A. Schmidt, E. Schuster, S. Kreuzer, F. Kainberger, H. Frisch, G. Geyer, WH. Hörl, G. Mayer, A. Luger

EFFECTS OF 12 MONTHS OF RECOMBINANT GROWTH HORMONE THERAPY ON PARAMETERS OF BONE METABOLISM AND BONE MINERAL DENSITY IN PATIENTS ON CHRONIC HEMODIALYSIS

Journal of Nephrology 2004 17: 87-94

V. Combes, AR. Rosenkranz, M. Redard, G. Pizzolato, H. Lepidi, D. Vestweber, TN. Mayadas, GE. Grau

PATHOGENIC ROLE OF P-SELECTIN IN EXPERIMENTAL CEREBRAL MALARIA: IMPORTANCE OF THE ENDOTHELIAL COMPARTMENT

American Journal of Pathology 2004 164: 781-786

H. Koller, K. Hochegger, GJ. Zlabinger, K. Lhotta, G. Mayer, AR. Rosenkranz

APOPTOSIS OF HUMAN POLYMORPHONUCLEAR NEUTROPHILS ACCELERATED BY DIALYSIS MEMBRANES VIA THE ACTIVATION OF THE COMPLEMENT SYSTEM

Nephrology Dialysis Transplantation 2004 19: 3104-3111

K. Hochegger, S. Knight, C. Hugo, G. Mayer, J. Lawler, TN. Mayadas, AR. Rosenkranz

ROLE OF THROMBOSPONDIN-1 IN THE AUTOLOGOUS PHASE OF AN ACCELERATED MODEL OF ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS

Nephron Experimental Nephrology 2004 96: 31-38

P. Jennings, C. Koppelstaetter, W. Pfaller, JP. Morin, T. Hartung, MP. Ryan

ASSESSMENT OF A NEW CELL CULTURE PERFUSION APPARATUS FOR IN VITRO CHRONIC TOXICITY TESTING. PART 2: TOXICOLOGICAL EVALUATION

ALTEX 2004 21: 61-66

C. Koppelstaetter, P. Jennings, MP. Ryan, JP. Morin, T. Hartung, W. Pfaller

ASSESSMENT OF A NEW CELL CULTURE PERFUSION APPARATUS FOR IN VITRO CHRONIC TOXICITY TESTING. PART 1: TECHNICAL DESCRIPTION

ALTEX 2004 21: 51-60

M. Tiefenthaler, S. Hofer, S. Ebner, L. Ivarsson, S. Neyer, M. Herold, G. Mayer, P. Fritsch, C. Heufler

IN VITRO TREATMENT OF DENDRITIC CELLS WITH TACROLIMUS: IMPAIRED T-CELL ACTIVATION AND IP-10 EXPRESSION

Nephrology Dialysis Transplantation 2004 19: 553-560

M. Rudnicki, S. Eder, G. Schratzberger, B. Mayer, TW. Meyer, M. Tonko, G. Mayer

RELIABILITY OF T7-BASED mRNA LINEAR AMPLIFICATION VALIDATED BY GENE EXPRESSION ANALYSIS OF HUMAN KIDNEY CELLS USING cDNA MICROARRAYS

Nephron Experimental Nephrology 2004 97: e86-e95

H. Koller, E. Zitt, G. Staudacher, U. Neyer, G. Mayer, AR. Rosenkranz

VARIABLE PARATHYROID HORMONE (1-84)/CARBOXYLTERMINAL PTH RATIOS DETECTED BY 4 NOVEL PARATHYROID HORMONE ASSAYS

Clinical Nephrology 2004 61: 337-343

P. Kotanko, R. Kramar, D. Devrnja, E. Paschke, T. Voigtländer, M. Auinger, K. Demmelbauer, M. Lorenz, AC. Hauser, HJ. Kofler, K. Lhotta, U. Neyer, W. Pronai, M. Wallner, C.Wieser, M. Wiesholzer, H. Zodl, M. Födinger, G. Sunder-Plassmann

RESULTS OF A NATIONWIDE SCREENING FOR ANDERSON-FABRY DISEASE AMONG DIALYSIS PATIENTS

Journal of the American Society of Nephrology 2004 15: 1323-1329

Y. Yang, K. Lhotta, EK. Chung, P. Eder, F. Neumair, CY. Yu

COMPLETE COMPLEMENT COMPONENTS C4A AND C4B DEFICIENCIES IN HUMAN KIDNEY DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS

Journal of Immunology 2004 173: 2803-2814

A. Löckinger, D. Köberle, PS. König, A. Saria, M. Herold, G. Cornélissen, F. Halberg

NEUROPEPTIDE CHRONOMICS IN CLINICALLY HEALTHY YOUNG ADULTS: CIRCAOCTOHORAN AND CIRCADIAN PATTERNS

Peptides 2004 25: 533-542

F. Kronenberg, A. Lingenhel, K. Lhotta, B. Rantner, MF. Kronenberg, P. König, J. Thiery, M. Koch, A. von Eckardstein, H. Dieplinger

THE APOLIPOPROTEIN(A) SIZE POLYMORPHISM IS ASSOCIATED WITH NEPHROTIC SYNDROME

Kidney International 2004 65: 606-612

F. Kronenberg, A. Lingenhel, K. Lhotta, B. Rantner, MF. Kronenberg, P. König, J. Thiery, M. Koch, A. von Eckardstein, H. Dieplinger

LIPOPROTEIN (A) - AND LOW-DENSITY LIPOPROTEIN-DERIVED CHOLESTEROL IN NEPHROTIC SYNDROME: IMPACT ON LIPID-LOWERING THERAPY?

Kidney International 2004 66: 348-354

M. Tiefenthaler, B. Gritsch, K. Zotter, G. Mayer

KOSTENREDUKTION DES DIALYSEBEGINNS DURCH RECHTZEITIGE FISTELANLAGE: UNTERSUCHUNGEN DER LKF-DATEN DER INZIDENTEN PATIENTEN VON 1999 BIS OKTOBER 2000 AM LANDESKRANKENHAUS INNSBRUCK/UNIVERSITÄTSKLINIKEN

Acta Medica Austriaca 2003 30: 121-126

D. Heininger-Rothbucher, M. Daxecker, H. Ulmer, W. Gritsch, C. Pechlaner, CJ. Wiedermann

PROBLEMATIC DRUGS IN ELDERLY PATIENTS PRESENTING TO A EUROPEAN EMERGENCY ROOM

European Journal of Internal Medicine 2003 14: 372-376

C. Mitterbauer, C. Schwarz, P. Hauser, R. Steininger, HM. Regele, A. Rosenkranz, R. Oberbauer

IMPAIRED TUBULOINTERSTITIAL EXPRESSION OF ENDOTHELIN-1 AND NITRIC OXIDE ISOFORMS IN DONOR KIDNEY BIOPSIES WITH POSTISCHEMIC ACUTE RENAL FAILURE

Transplantation 2003 76: 715-720

M. Wahrmann, M. Exner, H. Regele, K. Derfler, GF. Körmoczi, K. Lhotta, GJ. Zlabinger, GA. Böhmig

FLOW CYTOMETRY BASED DETECTION OF HLA ALLOANTIBODY MEDIATED CLASSICAL COMPLEMENT ACTIVATION

Journal of Immunological Methods 2003 275: 149-160

JJ. Turner, JM. Stacey, B. Harding, P. Kotanko, K. Lhotta, JG. Puig, I. Roberts, RJ. Torres, RV. Thakker

UROMODULIN MUTATIONS CAUSE FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY

Journal of Clinical Endocrinology and Metabolism 2003 88: 1398-1401

M. Tiefenthaler, N. Bacher, H. Linert, O. Mühlmann, S. Hofer, N. Sepp, A. Amberger, F. Geisen, G. Obermoser, G. Konwalinka

APOPTOSIS OF CD34+ CELLS AFTER INCUBATION WITH SERA OF LEUKOPENIC PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Lupus 2003 12: 471-478

K. Lhotta, M. Zoebl, G. Mayer, F. Kronenberg

LATE REFERRAL DEFINED BY RENAL FUNCTION: ASSOCIATION WITH MORBIDITY AND MORTALITY

Journal of Nephrology 2003 16: 855-861

F. Kronenberg, K. Lhotta, P. König, R. Margreiter, H. Dieplinger, G. Utermann

APOLIPOPROTEIN(A) ISOFORM-SPECIFIC CHANGES OF LIPOPROTEIN(A) AFTER KIDNEY TRANSPLANTATION

European Journal of Human Genetics 2003 11: 693-699

M. Tiefenthaler, F. Hohla, E. Strasser-Wozak, N. Bacher, O. Mühlmann, W.Wein, G. Konwalinka

DELAYED ADDITION OF DEOXYCYTIDINE PROTECTS NORMAL CD34+ CELLS AGAINST CYTOTOXICITY OF GEMCITABINE WITHOUT COMPROMISING ITS ACTIVITY AGAINST HUMAN LEUKEMIC CELLS

Stem Cells 2003 21: 266-271

M. Tiefenthaler, F. Hohla, E. Irschik, E. Strasser-Wozak, N. Bacher, O. Mühlmann, W. Wein, G. Konwalinka

IN VITRO STUDIES ON THE IMMUNOSUPPRESSIVE EFFECT OF 2’,2’-DIFLUORODEOXYCYTIDINE (dFdC) AND ITS METABOLITE 2’,2’- DIFLUORODEOXYURIDINE (dFdU)

Immunobiology 2003 207: 149-157

F. Kronenberg , A. Lingenhel, U. Neyer, K. Lhotta, P. König, M. Auinger, M. Wiesholzer, H. Andersson, H. Dieplinger

PREVALENCE OF DYSLIPIDEMIC RISK FACTORS IN HEMODIALYSIS AND CAPD PATIENTS

Kidney International 2003 84: S113-116

JM. Stacey, JJ. Turner, B. Harding, MA. Nesbit, P. Kotanko, K. Lhotta, JG. Puig, RJ. Torres, RV. Thakker

GENETIC MAPPING STUDIES OF FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY ON CHROMOSOME 16p11-p13

Journal of Clinical Endocrinology and Metabolism 2003 88: 464-470

G. Cohen, M. Rudnicki, R. Deicher, WH. Hörl

IMMUNOGLOBULIN LIGHT CHAINS MODULATE POLYMORPHONUCLEAR LEUCOCYTE APOPTOSIS

European Journal of Clinical Investigation 2003 33: 669-676

F. Wimmer, W. Oberaigner, R. Kramar, G. Mayer

REGIONAL VARIABILITY IN THE INCIDENCE OF END-STAGE RENAL DISEASE: AN EPIDEMIOLOGICAL APPROACH

Nephrology Dialysis Transplantation 2003 18: 1562-1567

G. Weiss, E. Meusburger, G. Radacher, K. Garimorth, U. Neyer, G. Mayer

EFFECT OF IRON TREATMENT ON CIRCULATING CYTOKINE LEVELS IN ESRD PATIENTS RECEIVING RECOMBINANT HUMAN ERYTHROPOIETIN

Kidney International 2003 64: 572-578

P. Wamser, R. Asari, P. Goetzinger, G. Mayer, G. Berlakovich, T. Soliman, F. Mühlbacher, R. Steininger

DETRIMENTAL EFFECTS OF CONTROLLED REPERFUSION ON RENAL FUNCTION AFTER PORCINE AUTOTRANSPLANTATION ARE FULLY COMPENSATED BY THE USE OF CAROLIN RINSE SOLUTION

Transplantation International 2003 16: 191-196

H. Kotzmann, A. Schmidt, P. Lercher, E. Schuster, G. Geyer, H. Frisch, WH. Hörl, G. Mayer, A. Luger

ONE-YEAR GROWTH HORMONE THERAPY IMPROVES GRANULOCYTE FUNCTION WITHOUT MAJOR EFFECTS ON NUTRITIONAL AND ANTHROPOMETRIC PARAMETERS IN MALNOURISHED HEMODIALYSIS PATIENTS

Nephron Clinical Practice 2003 93: C75-82

WH. Hörl, H. Holzer, G. Mayer, Österreichische Aranesp Studiengruppe

TREATMENT OF RENAL ANEMIA WITH DARBEPOETIN ALFA: RESULTS OF AN AUSTRIAN MULTICENTER STUDY

Wiener Klinische Wochenschrift 2002 114: 967-97

A. Sandhofer, C. Kahler, D. Heininger, R. Bellmann, CJ. Wiedermann, M. Joannidis

SEVERE ELECTROLYTE DISTURBANCES AND RENAL FAILURE IN ELDERLY PATIENTS WITH COMBINED DIURETIC THERAPY INCLUDING XIPAMID

Wiener Klinische Wochenschrift 2002 114: 938-942

M. Tiefenthaler, C. Riedl-Huter, T. Roth, G. Bodner, G. Mayer

ULTRASONIC DIAGNOSIS OF CALCIPHYLACTIC LESIONS

Ultraschall in der Medizin 2002 23: 403-406

C. Weidekamm, P. Hauser, C. Hansmann, C. Schwarz, H. Klingler, G. Mayer, R. Oberbauer

EFFECTS OF AT1 AND AT2 RECEPTOR BLOCKADE ON ANGIOTENSIN II INDUCED APOPTOSIS OF HUMAN RENAL PROXIMAL TUBULAR EPITHELIAL CELLS

Wiener Klinische Wochenschrift 2002 114: 725-729

C. Schwarz, P. Hauser, R. Steininger, H. Regele, G. Heinze, G. Mayer, R. Oberbauer

FAILURE OF BCL-2 UP-REGULATION IN PROXIMAL TUBULAR EPITHELIAL CELLS OF DONOR KIDNEY BIOPSY SPECIMENS IS ASSOCIATED WITH APOPTOSIS AND DELAYED GRAFT FUNCTION

Laboratory Investigation 2002 82: 941-948

F. Kronenberg, E. Kuen, E. Ritz, P. König, G. Kraatz, K. Lhotta, JF. Mann, GA. Müller, U. Neyer, W. Riegel, P. Riegler, V. Schwenger, A. von Eckardstein

APOLIPOPROTEIN A-IV SERUM CONCENTRATIONS ARE ELEVATED IN PATIENTS WITH MILD AND MODERATE RENAL FAILURE

Journal of the American Society of Nephrology 2002 13: 461-469

C. Schubert, W. Geser, B. Noisternig, P. König, G. Rumpold, A. Lampe

STRESSFUL LIFE EVENTS AND SKIN DISEASES: AN ADDITIONAL PERSPECTIVE FROM RESEARCH ON PSYCHOSOMATIC DYNAMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Psychotherapy and Psychosomatics 2002 71: 123-126

P. Schratzberger, J.G. Krainin, G. Schratzberger, M. Silver, H. Ma, M. Kearney, RF. Zuk, A.F. Brisken, D.W. Losordo, J.M. Isner

TRANSCUTANEOUS ULTRASOUND AUGMENTS NAKED DNA TRANSFECTION OF SKELETAL MUSCLE

Molecular Therapy 2002 6: 576-583

M. Haas, Z. Leko-Mohr, C. Erler, G. Mayer

ANTIPROTEINURIC VERSUS ANTIHYPERTENSIVE EFFECTS OF HIGH-DOSE ACE INHIBITOR THERAPY

American Journal of Kidney Diseases 2002 40: 458-463

A. Schmidt, J. Pleiner, M. Bayerle-Eder, GF. Wiesinger, S. Rodler, M. Quittan, G. Mayer, M. Wolzt

REGULAR PHYSICAL EXERCISE IMPROVES ENDOTHELIAL FUNCTION IN HEART TRANSPLANT RECIPIENTS

Clinical Transplantation 2002 16: 137-143

E. Peherstorfer, B. Mayer, S. Boehm, A. Lukas, P. Hauser, G. Mayer, R. Oberbauer

EFFECTS OF MICROINJECTION OF SYNTHETIC BCL-2 DOMAIN PEPTIDES ON APOPTOSIS OF RENAL TUBULAR EPITHELIAL CELLS

American Journal of Physiology and Renal Physiology 2002 283: F190-196

G. Cohen, M. Rudnicki, S. Schmaldienst, WH. Hörl

EFFECT OF DIALYSIS ON SERUM/PLASMA LEVELS OF FREE IMMUNO-GLOBULIN LIGHT CHAINS IN END-STAGE RENAL DISEASE PATIENTS

Nephrology Dialysis Transplantation 2002 17: 879-883

G. Mayer for the TIP Study Group

RESULTS FROM THE TIP (TRITACE IN PROTEINURIA) INTENSIFIED MONITORING PROJECTS

Kidney and Blood Pressure Research 2002 25: 80-86

A. Schmidt, J. Pleiner, G. Schaller, M. Roden, S. Dallinger, G. Mayer, L. Schmetterer, M. Wolzt

RENAL HEMODYNAMIC EFFECTS OF SOMATOSTATIN ARE NOT RELATED TO INHIBITION OF ENDOGENOUS INSULIN RELEASE

Kidney International 2002 61: 1788-1793

M. Haas, G. Mayer, G. Wirnsberger, H. Holzer, M. Ratschek, U. Neyer, J. Neuweiler, R. Kramar, B. Schneider, S. Breiteneder-Geleff, HR. Regele, WH. Hörl, D. Kerjaschki

ANTIOXIDANT TREATMENT OF THERAPY-RESISTANT IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH PROBUCOL: A PILOT STUDY

Wiener Klinische Wochenschrift 2002 114: 143-147

K. Lhotta, HJ. Rumpelt, P. König, G. Mayer, F. Kronenberg

CIGARETTE SMOKING AND VASCULAR PATHOLOGY IN RENAL BIOPSIES

Kidney International 2002 61: 648-654

C. Siehs, R. Oberbauer, G. Mayer, A. Lukas, B. Mayer

DISCRETE SIMULATION OF REGULATORY HOMO- AND HETERODIMERIZATION IN THE APOPTOSIS EFFECTOR PHASE

Bioinformatics 2002 18: 67-76

M. Tiefenthaler, A. Amberger, N. Bacher, BL. Hartmann, R. Margreiter, R. Kofler, G. Konwalinka

INCREASED LACTATE PRODUCTION FOLLOWS LOSS OF MITOCHONDRIAL MEMBRANE POTENTIAL DURING APOPTOSIS OF HUMAN LEUKAEMIA CELLS

British Journal of Haematology 2001 114: 574-580

AR. Rosenkranz, E. Peherstorfer, GF. Körmöczi, GJ. Zlabinger, G. Mayer, WH. Hörl, R. Oberbauer

COMPLEMENT-DEPENDENT ACCELERATION OF APOPTOSIS IN NEUTROPHILS BY DIALYZER MEMBRANES

Kidney International 2001 78: S216-S220

B. Nadel, R. Marculescu, T. Le, M. Rudnicki, S. Böcskör, U. Jäger

NOVEL INSIGHTS INTO THE MECHANISM OF T (14;18) (q32;q21) TRANSLOCATION IN FOLLICULAR LYMPHOMA

Leukemia and Lymphoma 2001 42: 1181-1194

G. Cohen, M. Rudnicki, WH. Hörl

UREMIC TOXINS MODULATE THE SPONTANEOUS APOPTOTIC CELL DEATH AND ESSENTIAL FUNCTIONS OF NEUTROPHILS

Kidney International 2001 78: S48-S52

G. Cohen, M. Rudnicki, F. Walter, T. Niwa, WH. Hörl

GLUCOSE-MODIFIED PROTEINS MODULATE ESSENTIAL FUNCTIONS AND APOPTOSIS OF POLYMORPHONUCLEAR LEUKOCYTES

Journal of the American Society of Nephrology 2001 12: 1264-1271

Y. Ren, L. Stuart, FP. Lindberg, AR. Rosenkranz, Y. Chen, TN. Mayadas, J. Savill

NONPHLOGISTIC CLEARANCE OF LATE APOPTOTIC NEUTROPHILS BY MACROPHAGES: EFFICIENT PHAGOCYTOSIS INDEPENDENT OF BETA 2 INTEGRINS

Journal of Immunology 2001 166: 4743-4750

GF. Körmöczi, UM. Wolfel, AR. Rosenkranz, WH. Hörl, R. Oberbauer, GJ. Zlabinger

SERUM PROTEINS MODIFIED BY NEUTROPHIL-DERIVED OXIDANTS AS MEDIATORS OF NEUTROPHIL STIMULATION

Journal of Immunology 2001 167: 451-460

H. Fischer, P. König, MP. Dierich, F. Allerberger

HEMOLYTIC-UREMIC SYNDROME SURVEILLANCE TO MONITOR TRENDS IN INFECTION WITH ESCHERICHIA COLI 0157 AND NON-0157 ENTERO-HEMORRHAGIC E. COLI IN AUSTRIA

Pediatric Infectious Disease Journal 2001 20: 316-318

AG. Bostom, F. Kronenberg, RY. Gohh, V. Schwenger, E. Kuen, P. König, G. Kraatz, K. Lhotta, JF. Mann, GA. Müller, U. Neyer, W. Riegel, P. Riegler, E. Ritz, J. Selhub

CHRONIC RENAL TRANSPLANTATION: A MODEL FOR THE HYPER-HOMOCYSTEINEMIA OF RENAL INSUFFICIENCY

Atherosclerosis 2001 156: 227-230

S. Christian, A. Lampe, G. Rumpold, W. Geser, B. Noisternig, E. Chamson, D. Schatz, P. König, D. Fuchs, G. Schüssler

DER EINFLUSS VON ALLTAGSBELASTUNGEN UND ASSOZIIERTEN EMOTIONEN AUF DEN DYNAMISCHEN VERLAUF VON CORTISOL UND NEOPTERIN BEI PATIENTINNEN MIT SYSTEMISCHEM LUPUS ERYTHEMATODES: ERGEBNISSE AUS ZWEI „INTEGRATIVEN EINZELFALLSTUDIEN“

Zeitschrift für Psychosomatische Medizin und Psychotherapie 2001 47: 58-79

AG. Bostom, F. Kronenberg, PF. Jacques, E. Kuen, E. Ritz, P. König, G. Kraatz, K. Lhotta, JF. Mann, GA. Müller, U. Neyer, W. Riegel, V. Schwenger, P. Riegler, J. Selhub

PROTEINURIA AND PLASMA TOTAL HOMOCYSTEINE LEVELS IN CHRONIC RENAL DISEASE PATIENTS WITH A NORMAL RANGE SERUM CREATININE: CRITICAL IMPACT OF TRUE GLOMERULAR FILTRATION RATE

Atherosclerosis 2001 159: 219-223

D. Heininger-Rothbucher, S. Bischinger, H. Ulmer, C. Pechlaner, G. Speer, CJ. Wiedermann

INCIDENCE AND RISK OF POTENTIAL ADVERSE DRUG INTERACTIONS IN THE EMERGENCY ROOM

Resuscitation 2001 49: 283-288

R. Oberbauer, Ch. Schwarz, HM. Regele, C. Hansmann, TW. Meyer, G. Mayer

REGULATION OF RENAL TUBULAR CELL APOPTOSIS AND PROLIFERATION AFTER ISCHEMIC INJURY TO A SOLITARY KIDNEY

Journal of Laboratory and Clinical Medicine 2001 138: 343-351

H. Kotzmann, N. Yilmaz, P. Lercher, M. Riedl, A. Schmidt, E. Schuster, S. Kreuz, G. Geyer, H. Frisch, WH. Hörl, G. Mayer, A. Luger

DIFFERENTIAL EFFECTS OF GROWTH HORMONE THERAPY IN MALNOURISHED HEMODIALYSIS PATIENTS

Kidney International 2001 60: 1578-1585

A. Schmidt, M. Bayerle-Eder, H. Pleiner, C. Zeisner, M. Wolzt, G. Mayer, L. Schmetterer

THE RENAL AND SYSTEMIC HEMODYNAMIC EFFECTS OF A NITRIC OXIDE-SYNTHASE INHIBITOR ARE REVERSED BY A SELECTIVE ENDOTHELIN(A) RECEPTOR ANTAGONIST IN MEN

Nitric Oxide 2001 5: 370-376

C. Schwarz, H. Regele, R. Steininger, C. Hansmann, G. Mayer, R. Oberbauer

THE CONTRIBUTION OF ADHESION MOLECULE EXPRESSION IN DONOR KIDNEY BIOPSIES TO EARLY ALLOGRAFT DYSFUNCTION

Transplantation 2001 71: 1666-1670

J. Bergler-Klein, C. Pirich, G. Laufer, M. Grimm, H. Regele, G. Mayer, R. Oberbauer

THE LONG-TERM EFFECT OF SIMULTANEOUS HEART AND KIDNEY TRANSPLANTATION ON NATIVE RENAL FUNCTION

Transplantation 2001 71: 1597-1600

U. Barnas, A. Schmidt, G. Seidl, A. Kaider, P. Pietschmann, G. Mayer

A COMPARISON OF QUANTITATIVE COMPUTED TOMOGRAPHY AND DUAL X-RAY ABSORPTIOMETRY FOR EVALUATION OF BONE MINERAL DENSITY IN PATIENTS ON CHRONIC HEMODIALYSIS

American Journal of Kidney Diseases 2001 37: 1247-1252

A. Schmidt, U. Gruber, G. Böhmig, E. Koller, G. Mayer

THE EFFECT OF ACE INHIBITOR AND ANGIOTENSIN II RECEPTOR ANTAGONIST THERAPY ON SERUM URIC ACID LEVELS AND POTASSIUM HOMEOSTASIS IN HYPERTENSIVE RENAL TRANSPLANT RECIPIENTS TREATED WITH CSA

Nephrology Dialysis Transplantation 2001 16: 1034-1037

C. Schwarz, GA. Böhmig, R. Steininger, G. Mayer, R. Oberbauer

IMPAIRED PHOSPHATE HANDLING OF RENAL ALLOGRAFTS IS AGGRAVATED UNDER RAPAMYCIN-BASED IMMUNOSUPPRESSION

Nephrology Dialysis Transplantation 2001 16: 378-382

A. Schmidt, T. Stefenelli, E. Schuster, G. Mayer

INFORMATIONAL CONTRIBUTION OF NONINVASIVE SCREENING TESTS FOR CORONARY ARTERY DISEASE IN PATIENTS ON CHRONIC RENAL REPLACEMENT THERAPY

American Journal of Kidney Diseases 2001 37: 56-63

R. Oberbauer, V. Nenov, C. Weidekamm, M. Haas, T. Szekeres, G. Mayer

REDUCTION IN MEAN GLOMERULAR PORE SIZE COINCIDES WITH THE DEVELOPMENT OF LARGE SHUNT PORES IN PATIENTS WITH DIABETIC NEPHROPATHY

Experimental Nephrology 2001 98: 49-53

H. Strasser, M. Tiefenthaler, M. Steinlechner, I. Eder, G. Bartsch, G. Konwalinka

AGE DEPENDENT APOPTOSIS AND LOSS OF RHABDOSPHINCTER CELLS

Journal of Urology 2000 164: 1781-1785

IE. Eder, Z. Culig, R. Ramoner, M. Thurnher, T. Putz, C. Nessler-Menardi, M. Tiefenthaler, G. Bartsch, H. Klocker

INHIBITION OF LncaP PROSTATE CANCER CELLS BY MEANS OF ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES

Cancer Gene Therapy 2000 7: 997-1007

P. Schratzberger, G. Schratzberger, M. Silver, C. Curry, M. Kearney, M. Magner, J. Alroy, LS. Adelman, DH. Weinberg, AH. Ropper, JM. Isner

FAVORABLE EFFECT OF VEGF GENE TRANSFER ON ISCHEMIC PERIPHERAL NEUROPATHY

Nature Medicine 2000 6: 405-413

P. Schenk, AR. Rosenkranz, G. Wölfl, WH. Hörl, O. Traindl

RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR IS A USEFUL ALTERNATIVE TO HEPARIN IN PRIMING QUINTON PERMCATH

American Journal of Kidney Disease 2000 35: 130-136

S. Schmaldienst, F. Traunmüller, H. Burgmann, AR. Rosenkranz, R. Thalhammer-Scherrer, WH. Hörl, F. Thalhammer

MULTIPLE-DOSE PHARMACOKINETICS OF CEFEPIME IN LONG-TERM HEMODIALYSIS WITH HIGH-FLUX MEMBRANES

European Journal of Clinical Pharmacology 2000 56: 61-64

AR. Rosenkranz, S. Knight, S. Sethi, SI. Alexander, RS. Cotran, TN. Mayadas

REGULATORY INTERACTIONS OF αβ AND γδ T CELLS IN GLOMERULO-NEPHRITIS

Kidney International 2000 58: 1055-1066

F. Kronenberg, E. Kuen, E. Ritz, R. Junker, P. König, G. Kraatz, K. Lhotta, JF. Mann, GA. Muller, U. Neyer, W. Riegel, P. Reigler, V. Schwenger, A. Von Eckardstein

LIPOPROTEIN(A) SERUM CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN MILD AND MODERATE RENAL FAILURE

Journal of the American Society of Nephrology 2000 11: 105-115

T. Kos, P. Moser, N. Yilmatz, G. Mayer, R. Pacher, S. Hallström

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF p-AMINOHIPPURIC ACID AND IOTHALAMATE IN HUMAN SERUM AND URINE: COMPARISON OF TWO SAMPLE PREPARATION METHODS

Journal of Chromatography 2000 740: 81-85

M. Schirmer, F. Geisen, M. Tiefenthaler, G. Konwalinka

DIFFERENTIAL EFFECTS OF CLADRIBINE AND GEMCITABINE ON ERYTHROID AND GRANULOCYTIC PROGENITORS FROM PATIENTS WITH CHRONIC MYELOID LEUKEMIA

Leukemia Research 1999 23: 1121-1126

C. Zidorn, H. Stuppner, M. Tiefenthaler, G. Konwalinka

CYTOTOXIC ACTIVITIES OF HYPOCRETENOLIDES FROM LEONTODON HISPIDUS

Journal of Natural Products 1999 62: 984-987

R. Margreiter, M. Fischer, K. Roberts, T. Schmid, A. Hittmair, M. Schirmer, F. Geisen, M. Tiefenthaler, G. Konwalinka

GEMCITABINE – A NOVEL IMMUNOSUPPRESSIVE AGENT – PREVENTS REJECTION IN A RAT CARDIAC TRANSPLANTATION MODEL

Transplantation 1999 68: 1051-1053

M. Tiefenthaler, R. Marksteiner, S. Neyer , F. Koch, S. Hofer, G. Schuler, M. Nussenzweig, R. Schneider, C. Heufler

M1204, A NOVEL 2´,5´ OLIGOADENYLATE SYNTHETASE WITH A UBIQUITIN-LIKE EXTENSION, IS INDUCED DURING MATURATION OF MURINE DENDRITIC CELLS

The Journal of Immunology 1999 163: 760-765

F. Kronenberg, U. Neyer, K. Lhotta, E. Trenkwalder, M. Auinger, A. Pribasnig, T. Meisl, P. König, H. Dieplinger

THE LOW MOLECULAR WEIGHT APO (A) PHENOTYPE IS AN INDEPENDENT PREDICTOR FOR CORONARY ARTERY DISEASE IN HEMODIALYSIS PATIENTS: A PROSPECTIVE FOLLOW-UP

Journal of the American Society of Nephrology 1999 10: 1027-1036

L. Kerschdorfer, P. König, U. Neyer, C. Bösmüller, K. Lhotta, M. Auinger, M. Hohenegger, P. Riegler, R. Margreiter, G. Utermann, H. Dieplinger, F. Kronenberg

LIPOPROTEIN (A) PLASMA CONCENTRATIONS AFTER RENAL TRANSPLANTATION: A PROSPECTIVE EVALUATION AFTER 4 YEARS OF FOLLOW-UP

Atherosclerosis 1999 144: 381-391

K. Lhotta, R. Wurzner, P. König

GLOMERULAR DEPOSITION OF MANNOSE-BINDING LECTIN IN HUMAN GLOMERULONEPHRITIS

Nephrology Dialysis Transplantation 1999 14: 881-886

C. Schubert, A. Lampe, G. Rumpold, D. Fuchs, P. König, E. Chamson, G. Schüssler

DAILY PSYCHOSOCIAL STRESSORS INTERFERE WITH THE DYNAMICS OF URINE NEOPTERIN IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: AN INTEGRATIVE SINGLE-CASE STUDY

Psychosomatic Medicine 1999 61: 876-882

D. Rabensteiner, H. Abrahamian, K. Irsigler, KM. Hermann, HP. Kiener, G. Mayer, A. Kaider, R. Prager

ACE GENE POLYMORPHISM AND PROLIFERATIVE RETINOPATHY IN TYPE 1 DIABETES: RESULTS OF A CASE-CONTROL STUDY

Diabetes Care 1999 22: 1530-1550

R. Oberbauer, M. Rohrmoser, H. Regele, F. Mühlbacher, G. Mayer

APOPTOSIS OF TUBULAR EPITHELIAL CELLS IN DONOR KIDNEY BIOPSIES PREDICTS EARLY RENAL ALLOGRAFT FUNCTION

Journal of the American Society of Nephrology 1999 10: 2006-2013

J. Kletzmayr, G. Mayer, E. Legenstein, G. Heinz-Peer, T. Leitha, WH. Hörl, J. Kovarik

ANEMIA AND CARNITINE SUPPLEMENTATION IN HEMODIALYZED PATIENTS

Kidney International 1999 55: S93-S106

AR. Rosenkranz, DL. Mendrick, RS. Cotran, TN. Mayadas

P-SELECTIN DEFICIENCY EXACERBATES EXPERIMENTAL GLOMERULO-NEPHRITIS: A PROTECTIVE ROLE FOR ENDOTHELIAL P-SELECTIN IN INFLAMMATION

Journal of Clinical Investigation 1999 103: 649-659

AR. Rosenkranz, GF. Körmöczi, F. Thalhammer, EJ. Menzel, WH. Hörl, G. Mayer, GJ. Zlabinger

NOVEL C5-DEPENDENT MECHANISM OF NEUTROPHIL STIMULATION BY BIOINCOMPATIBLE DIALYZER MEMBRANES

Journal of the American Society of Nephrology 1999 10: 128-135

M. Mack, AR. Rosenkranz

BASOPHILS AND MAST CELLS IN RENAL INJURY

Kidney International 2009 76: 1142-1147

C. Koppelstaetter, G. Kern, G. Mayer

BIOMARKERS OF AGING WITH PROGNOSTIC AND PREDICTIVE VALUE IN NON-ONCOLOGICAL DISEASES

Current Medicinal Chemistry 2009 16: 3469-3475

SJ. Noppert, G. Mayer

IN SEARCH FOR THE TROPONIN OF THE KIDNEY

Current Medicinal Chemistry 2009 16: 4219-4229

P. Perco, J. Wilflingseder, A. Bernthaler, M. Wiesinger, M. Rudnicki, B. Wimmer, B. Mayer, R. Oberbauer

BIOMARKER CANDIDATES FOR CARDIOVASCULAR DISEASE AND BONE METABOLISM DISORDERS IN CHRONIC KIDNEY DISEASE: A SYSTEMS BIOLOGY PERSPECTIVE

Journal of Cellular and Molecular Medicine 2008 12: 1177-1187

K. Hochegger, AR. Rosenkranz, F. Siebenhaar, M. Maurer

COMMENT ON “MAST CELL-MEDIATED REMODELING AND FIBRINOLYTIC ACTIVITY PROTECT AGAINST FATAL GLOMERULONEPHRITIS“

Journal of Immunology 2006 177: 1377

H. Koller, G. Mayer

EVALUATION OF THE LIVING KIDNEY DONOR

Nephrology Dialysis Transplantation 2004 19 Suppl. 4: iv41-44

Y. Yang, EK. Chung, B. Zhou, K. Lhotta, LA. Hebert, DJ. Birmingham, BH. Rovin, CY. Yu

THE INTRICATE ROLE OF COMPLEMENT COMPONENT C4 IN HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS

Current Dir. Autoimmunity 2004 7: 98-132

M. Rudnicki, G. Mayer

PHARMACOGENOMICS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN RENAL DISEASE - PATHOPHYSIOLOGICAL CONSIDERATIONS

Pharmacogenomics 2003 4: 153-162

G. Mayer

REMISSION VON CHRONISCHEN NIERENERKRANKUNGEN: EIN REALISTISCHES ZIEL?

Wiener Klinische Wochenschrift 2003 115: 405-406

K. Hochegger, AR. Rosenkranz

SYSTEMISCHE EFFEKTE DES AKUTEN NIERENVERSAGENS

Wiener Klinische Wochenschrift 2003 23a: 12-16

K. Lhotta

NEUE ASPEKTE AUS PATHOPHYSIOLOGIE UND THERAPIE DER RENALEN ANÄMIE

Arzt und Praxis 2003 881/882: 332-335

G. Schratzberger, G. Mayer

AGE AND RENAL TRANSPLANTATION: AN INTERIM ANALYSIS

Nephrology Dialysis Transplantation 2003 18: 471-476

K. Lhotta

BEYOND HEPATORENAL SYNDROME: GLOMERULONEPHRITIS IN PATIENTS WITH LIVER DISEASE

Seminars in Nephrology 2002 22: 302-308

G. Mayer

ACE GENOTYPE AND ACE INHIBITOR RESPONSE IN KIDNEY DISEASE: A PERSPECTIVE

American Journal of Kidney Diseases 2002 40: 227-235

G. Schratzberger, G. Mayer

CHRONIC ALLOGRAFT FAILURE: A DISEASE WE DON´T UNDERSTAND AND CAN´T CURE?

Nephrology Dialysis Transplantation 2002 17: 1384-1390

M. Haas, G. Mayer

ANTIOXIDANT THERAPY IN GLOMERULAR DISEASE

Wiener Klinische Wochenschrift 2002 114: 138-140

H. Koller, G. Mayer

NIERENERSATZTHERAPIE BEIM ÄLTEREN PATIENTEN

Wiener Klinische Wochenschrift 2001 23-24a: 12-20

H. Koller, G. Mayer

IMMUNOSUPPRESSIVE THERAPY AND BONE METABOLISM AFTER KIDNEY TRANSPLANTATION

Acta Medica Austriaca 2001 28: 81-85

K. Lhotta

PATHOGENESIS AND CLINICAL COURSE OF HEREDITARY NEPHROPATHIES

Acta Medica Austriaca 2001 28: 78-80

M. Tiefenthaler, C. Riedl-Huter

STELLENWERT DER SONOGRAPHIE IN DER NIERENTRANSPLANTATION

Acta Medica Austriaca 2001 28: 74-77

P. König

NIERENLEBENDSPENDE – AUSWAHLKRITERIEN, VORBEREITUNG UND NACHSORGE

Acta Medica Austriaca 2001 28: 70-73

AR. Rosenkranz

HYPERTENSION AND CHRONIC RENAL INSUFFICIENCY

Acta Medica Austriaca 2001 28: 66-69

G. Mayer

EDITORIAL: WAS MACHT EIGENTLICH EIN NEPHROLOGE?

Acta Medica Austriaca 2001 28: 61-65

G. Mayer

CARDIAC DISEASE – WHAT IS DIFFERENT IN PATIENTS WITH RENAL INSUFFICIENCY?

Journal of Clinical and Basic Cardiology 2001 4: 88

H. Fischer, P. König, MP. Dierich, F. Allerberger

ERKRANKUNGEN DURCH ENTEROHÄMORRHAGISCHE ESCHERICHIA COLI

Pädiatrische Praxis 2001 59: 447-453

P. König

NEGATIVE KLINISCHE ASPEKTE DER GLUKOSE ALS OSMOTISCHES AGENS IN PERITONEALDIALYSELÖSUNGEN

Wiener Klinische Wochenschrift 2000 11: 38-42

AR. Rosenkranz

CARL LUDWIG AWARD 2000: EXPERIMENTAL GLOMERULONEPHRITIS: THE USE OF GENETICALLY DEFICIENT MICE TO ELUCIDATE THE ROLE OF LEUKOCYTES AND LEUKOCYTE ADHESION RECEPTORS

Kidney and Blood Pressure Research 2000 23: 152-153

A. Rosenkranz, G. Mayer

MECHANISMS OF HYPERTENSION AFTER RENAL TRANSPLANTATION

Current Opinion in Urology 2000 10: 81-86

AR. Rosenkranz, G. Mayer

PROTEINURIA IN THE TRANSPLANTED PATIENT

Nephrology Dialysis Transplantation 2000 15: 1290-1292

AR. Rosenkranz, TN. Mayadas

LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS - LESSONS FROM KNOCKOUT MICE

Experimental Nephrology 1999 7: 125-136

GF. Körmöczi, AR. Rosenkranz, GJ. Zlabinger

POLYMORPHONUCLEAR GRANULOCYTE STIMULATION BY CELLULOSE-BASED HEMODIALYSIS MEMBRANES

Clinical Chemistry and Laboratory Medicine 1999 37: 351-355

TN. Mayadas, A. Rosenkranz, RS. Cotran

GLOMERULAR INFLAMMATION: USE OF GENETICALLY DEFICIENT MICE TO ELUCIDATE THE ROLES OF LEUKOCYTE ADHESION MOLECULES AND FC-GAMMA RECEPTORS IN VIVO

Current Opinion in Nephrology and Hypertension 1999 8: 293-298

H. Fischer, HM. Verwyen, LB. Zimmerhackl, P. König, PA. Kyrle, K. Grif, F. Allerberger

ENTEROHÄMORRHAGISCHE ESCHERICHIA COLI UND HÄMOLYTISCH-URÄMISCHES SYNDROM

Antibiotika Monitor 1999 5: 82-88

M. Haas, D. Kerjaschki, G. Mayer

LIPID-LOWERING THERAPY IN MEMBRANOUS NEPHROPATHY

Kidney International 1999 56: 110-112

RL. Benz, M. Jadoul, JM. López Gómez, M. Martins, G. Mayer, RW. van Olden, A. Piccoli, DS. Silverberg, V. Teplan, CG. Winearls
Chairman´s Workshop Report

HOW SHOULD ANAEMIA BE MANAGED IN PRE-DIALYSIS PATIENTS?

Nephrology Dialysis Transplantation 1999 14(S2): 67-75

A. Schmidt, G. Mayer

THE DIAGNOSTIC TRASH BIN OF FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS - AN EFFORT TO PROVIDE RATIONAL CLINICAL GUIDELINES

Nephrology Dialysis Transplantation 1999 14: 550-552

G. Mayer

RENAL FUNCTION IN THE ELDERLY AND DRUG DOSING

Gerontology 2009 55: 417-421

K. Hochegger, M. Rudnicki, M. Auinger, W. Mark, R. Margreiter, G. Mayer, AR. Rosenkranz

FEVER OF UNKNOWN ORIGIN IN RENAL TRANSPLANT PATIENTS WITH TACROLIMUS

Clinical Transplantation 2009 23: 575-579

H. Bonatti, G. Brandacher, C. Bösmüller, M. Cont, P. Hengster, AR. Rosenkranz, J. Krugmann, R. Margreiter

HEMOLYTIC UREMIC SYNDROME FOLLOWING CAMPATH-1H INDUCTION

Transplant International 2007 20: 386-389

H. Koller, C. Pechlaner, K. Lhotta, G. Mayer, AR. Rosenkranz

A HIDDEN CAUSE OF ANGINA PECTORIS: WHEN ABG ANALYSIS IS THE ONLY HELPFUL DIAGNOSTIC TOOL

International Journal of Cardiology 2006 109: 414-416

H. Koller, W. Steurer, W. Mark, R. Margreiter, K. Lhotta, G. Mayer, AR. Rosenkranz

CLEARANCE OF C4D DEPOSITION AFTER SUCCESSFUL TREATMENT OF ACUTE HUMORAL REJECTION IN FOLLOW-UP BIOPSIES: A REPORT OF THREE CASES

Transplant International 2004 17: 177-181

A. Brunner, A. Tzankov, T. Akkad, K. Lhotta, G. Bartsch, G. Mikuz

WEGENER’S GRANULOMATOSIS PRESENTING WITH GROSS HEMATURIA DUE TO PROSTATITIS

Virchows Archiv 2004 444: 92-94

K. Lhotta, R. Wurzner, HJ. Rumpelt, P. Eder, G. Mayer

MEMBRANOUS NEPHROPATHY IN A PATIENT WITH HEREDITARY COMPLETE COMPLEMENT C4 DEFICIENCY

Nephrology Dialysis Transplantation 2004 19: 990-993

K. Lhotta, R. Wurzner, AR. Rosenkranz, R. Beer, A. Rudisch, F. Neumair, G. Mayer

CEREBRAL VASCULITIS IN A PATIENT WITH HEREDITARY COMPLETE C4 DEFICIENCY AND SYSTEMIC LUPUS ERYTHEMATOSUS

Lupus 2004 13: 139-141

P. Eller, AR. Rosenkranz, W. Mark, I. Theurl, J. Laufer, K. Lhotta

FOUR CONSECUTIVE RENAL TRANSPLANTATIONS IN A PATIENT WITH ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY

Clinical Nephrology 2004 61: 217-221

G. Pölzl, K. Lhotta, M. Tiefenthaler, A. Smekal, S. Müller

BILATERAL PERIRENAL FLUID ACCUMULATION ASSOCIATED WITH EISENMENGER'S SYNDROME

Nephrology Dialysis Transplantation 2004 19: 1928-1929

H. Koller

FALLBERICHT: RENOVASKULÄRE HYPERTONIE BEI SYSTEMISCHEM LUPUS ERYTHEMATHODES UND SEKUNDÄREM ANTIPHOSPHOLIPIDSYNDROM

Journal für Hypertonie 2004 3: 20-22

W. Sturm, H. Gaenzer, D. Heininger-Rothbucher, G. Neumayr, R. Kirchmair, J. Patsch, G. Weiss

UNSUSPECTED MESENTERIC VEIN THROMBOSIS IN A PATIENT WITH A HEREDITARY BLEEDING DISORDER

Blood Coagulation & Fibrinolysis 2003 14: 599-600

C. Schubert, A. Lampe, W. Geser, B. Noisternig, D. Fuchs, P. König, E. Chamson, G. Schüssler

DAILY PSYCHOSOCIAL STRESSORS AND CYCLIC RESPONSE PATTERNS IN URINE CORTISOL AND NEOPTERIN IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Psychoneuroendocrinology 2003 28: 459-473

M. Sarcletti, A. Petter, N. Romani, K. Lhotta, P. König, H. Maier, R. Zangerle

PYURIA IN PATIENTS TREATED WITH INDINAVIR IS ASSOCIATED WITH RENAL DYSFUNCTION

Clinical Nephrology 2000 54: 261-270

M. Haas, J. Kletzmayer, T. Staudinger, G. Böhmig, G. Mayer, Z. Leko-Mohr, W. Druml

HYPOTHYROIDISM AS A CAUSE OF TACROLIMUS INTOXICATION AND ACUTE RENAL FAILURE: A CASE REPORT

Wiener Klinische Wochenschrift 2000 112: 939-941

G. Finkenstedt, RW. Gasser, G. Höfle, K. Lhotta, D. Kolle, A. Gschwendtner, G. Janetschek

PHEOCHROMOCYTOMA AND SUB-CLINICAL CUSHING'S SYNDROME DURING PREGNANCY: DIAGNOSIS, MEDICAL PRE-TREATMENT AND CURE BY LAPAROSCOPIC UNILATERAL ADRENALECTOMY

Journal of Endocrinological Investigation 1999 22: 551-557

K. Lhotta, T. Kuhr, HJ. Rumpelt, E. Wöll, J. Thaler, P. König

THROMBOTIC MICROANGIOPATHY WITH RENAL FAILURE IN TWO PATIENTS UNDERGOING GEMCITABINE CHEMOTHERAPY

American Journal of Nephrology 1999 19: 590-593

G. Bodner, A. Gluck, P. Springer, P. König, R. Perkmann

ANEURYSMAL PORTOSYSTEMIC VENOUS SHUNT: A CASE REPORT

Ultraschall in der Medizin 1999 20: 215-217

E. Reiter, P. Kalhs, F. Keil, W. Rabitsch, H. Gisslinger, G. Mayer, N. Worel, K. Lechner, H. Greinix

EFFECT OF HIGH-DOSE MELPHALAN AND PERIPHERAL BLOOD STEM CELL TRANSPLANTATION ON RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA AND RENAL INSUFFICIENCY: A CASE REPORT AND REVIEW OF THE LITERATURE

Annals of Hematology 1999 78: 189-191

GA. Böhmig, S. Schmaldienst, WH. Hörl, G. Mayer

IATROGENIC HYPERCALCEMIA, HYPOKALEMIA AND METABOLIC ALKALOSIS IN A LADY WITH VENA CAVA THROMBOSIS-BEWARE OF OVERZEALOUS DIURETIC TREATMENT

Nephrology Dialysis Transplantation 1999 14: 782-784

K. Eller, I. Tancevski, P. Eller

LOWER MORTALITY FROM CORONARY HEART DISEASE AND STROKE AT HIGHER ALTITUDES IN SWITZERLAND

Circulation. 2010 121: e377

H. Koller, AR. Rosenkranz

PREVENTION OF ACUTE RENAL FAILURE WITH N-ACETYLCYSTEINE – ENOUGH IS ENOUGH?

Kidney International 2004 66: 1292-1293

K. Lhotta

PERFORMANCE OF GFR FORMULAS IN INDIVIDUALS WITH NORMAL RENAL FUNCTION

American Journal of Kidney Diseases 2004 44: 939-940

K. Hochegger, P. Eller, AR. Rosenkranz

GRANZYME A: AN ADDITIONAL WEAPON OF HUMAN POLYMORPHONUCLEAR NEUTROPHILS (PMNs) IN INNATE IMMUNITY?

Blood 2004 103: 1176

K. Hochegger, GJ. Mayer, AR. Rosenkranz

IS HIV INFECTION A CONTRAINDICATION FOR KIDNEY TRANSPLANTATION?

Nephrology Dialysis Transplantation 2003 18: 217-218

K. Lhotta

STOPPING PROGRESSION IN FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY WITH BENZBROMARONE?

Kidney International 2003 64: 1920-1921

K. Lhotta, P. König, G. Mayer, M. Oppermann

GLOMERULAR CELLS DO NOT EXPRESS THE C5a RECEPTOR IN HUMAN GLOMERULONEPHRITIS

Nephrology Dialysis Transplantation 2000 15: 1888-1889

P. Jennings, C. Koppelstätter, J. Lechner, W. Pfaller

RENAL CELL CULTURE MODELS: CONTRIBUTION TO THE UNDERSTANDING OF NEPHROTOXIC MECHANISMS

Clinical Nephrotoxins, Renal Injury from Drugs and Chemicals, Hrsg. Marc E. De Broe, George A. Porter
Springer New York/USA, 2008: 223-249, ISBN-13: 978-0-387-84842-6

G. Mayer

DIABETISCHE FOLGESCHÄDEN: DIABETISCHE NEPHROPATHIE
THERAPIE: HYPERTONIE

Risikofaktor Diabetes – Konzepte für ein Langzeitproblem, Hrsg. Prof. Dr. Bernhard Ludvik
UNI-MED Verlag AG, Bremen, 2004: 44-49, 110-114, ISBN 3-89599-824-9

R. Oberbauer, G. Mayer

STÖRUNGEN DES ELEKTROLYT- UND SÄURE-BASENHAUSHALTS BEI DER HÄMODIALYSE

Dialyseverfahren in Klinik und Praxis, Hrsg. WH. Hörl, C. Wanner, 2004:345-360
Georg Thieme Verlag Stuttgart, ISBN 3-13-497706-0

AR. Rosenkranz, G. Mayer

GLOMERULÄRE ERKRANKUNGEN

Medizinische Therapie in Klinik und Praxis, Hrsg. J. Schölmerich, 2003:970-978
Springer Verlag Berlin, ISBN 3-540-42218-8

G. Mayer

DIE ARTERIELLE HYPERTONIE AUS NEPHROLOGISCHER SICHT

Hypertonie interdisziplinär. Ein Kompendium für die Praxis, Hrsg. B. Eber, 2003:77-86
Hans Marseille Verlag GmbH München

FP. Schena, MD. Pascoe, J. Alberu, M. del Carmen Rial, R. Oberbauer, DC. Brennan, JM. Campistol, L. Racusen, MS. Polinsky, R. Goldberg-Alberts, H. Li, J. Scarola, JF. Neylan; Sirolimus CONVERT Trial Study Group

CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS MAINTENANCE THERAPY IN RENAL ALLOGRAFT RECIPIENTS: 24-MONTH EFFICACY AND SAFETY RESULTS FROM THE CONVERT TRIAL

Transplantation 2009 87: 233-242

R. Oberbauer, G. Mayer

THE 9TH INTERNATIONEL WYETH TRANSPLANTATION SYMPOSIUM: “PHASES, STAGES AND RISK FACTORS - CONSIDERING NEW IMMUNOSUPPRESSIVE STRATEGIES FOR RENAL TRANSPLANT PATIENTS.“

Transplantation Proceedings 2009 41(6 Suppl): S1

M. Haag-Weber, A. Vetter, U. Thyroff-Friesinger; INJ-Study Group

THERAPEUTIC EQUIVALENCE, LONG-TERM EFFICACY AND SAFETY OF HX575 IN THE TREATMENT OF ANEMIA IN CHRONIC RENAL FAILURE PATIENTS RECEIVING HEMODIALYSIS

Clinical Nephrology 2009 72: 380-390